(Q33367685)

English

Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR). (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

thrombocytopenia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

heparin-induced thrombocytopenia

1 reference

based on heuristic

inferred from title

author name string

John R Bartholomew

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Marcie J Hursting

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 June 2005

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Journal of Thrombosis and Thrombolysis

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

183-188

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-1849-9

21 January 2018

Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-1849-9

21 January 2018

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-1849-9

21 January 2018

The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-1849-9

21 January 2018

Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-1849-9

21 January 2018

Risk factors for intracranial hemorrhage in outpatients taking warfarin

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-1849-9

21 January 2018

Argatroban anticoagulation in patients with heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of heparin-induced thrombocytopenia: a critical review

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of lepirudin, argatroban, and melagatran on prothrombin time and additional effect of oral anticoagulation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of pharmacokinetic interactions between argatroban and warfarin

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factor X values as a means to assess the extent of oral anticoagulation in patients receiving antithrombin drugs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benefit-risk assessment of treatments for heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin‐induced thrombocytopenia: pathogenesis and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interpreting the International Normalized Ratio (INR) in individuals receiving argatroban and warfarin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of the patient population on the risk for heparin-induced thrombocytopenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The International Normalized Ratio during concurrent warfarin and argatroban anticoagulation: differential contributions of each agent and effects of the choice of thromboplastin used.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11239-005-1849-9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33367685&oldid=2195290806"